Longitudinal Microbial and Molecular Dynamics in the Cystic Fibrosis Lung after Elexacaftor-Tezacaftor-Ivacaftor therapy

BACKGROUND: Cystic fibrosis (CF) is a genetic disorder causing poor mucociliary clearance in the airways and subsequent respiratory infection. The recently approved triple therapy Elexacaftor-Tezacaftor-Ivacaftor (ETI) has significantly improved the lung function and decreased airway infection of pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Christian, Guzior, Douglas V., Gonzalez, Cely T., Okros, Maxwell, Mielke, Jenna, Padillo, Lienwil, Querido, Gabriel, Gil, Marissa, Thomas, Ryan, McClelland, Marc, Conrad, Doug, Widder, Stefanie, Quinn, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571617/
https://www.ncbi.nlm.nih.gov/pubmed/37841851
http://dx.doi.org/10.21203/rs.3.rs-3356170/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571617/
https://www.ncbi.nlm.nih.gov/pubmed/37841851
http://dx.doi.org/10.21203/rs.3.rs-3356170/v1

Ejemplares similares